Condition
Laparoscopic Bariatric Surgery
ClinicalTrials.gov condition label
How to interpret these research links
Connected source recordsThis is the original ClinicalTrials.gov condition label, found in 4 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
Advertisement
Clinical trials
4 shownEfficacy of Nebulized Dexmedetomidine on Blunting Hemodynamic Changes During Intubation and Pneumoperitoneum in Morbid Obese Patients During Laparoscopic Bariatric SurgeryNCT07054138 · 2025-07-10
COMPLETEDAminophylline on Perioperative Lung Mechanics in COPD Morbidly Obese Patients Undergoing Laparoscopic Bariatric SurgeryNCT06125665 · 2023-11-11
UNKNOWNPreoperative Nebulized Dexmedetomidine on Hemodynamic Changes in Laparoscopic Bariatric Surgery.NCT06014359 · 2023-08-27
UNKNOWNLaparoscopic Bariatric Surgery: Impact of Deep Neuromuscular Block on Surgical ConditionsNCT02118844 · 2014-07-01
UNKNOWNCommon interventions
Leading sponsors
Trial status mix
UNKNOWN3
COMPLETED1
Phase mix
NA3
PHASE41
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.